These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

6303 related items for PubMed ID: 3405342

  • 1. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. IV. Therapy of murine melanoma B16 by human serum albumin-methotrexate derivative.
    Bostík J, Bures L, Spundová M.
    Neoplasma; 1988; 35(3):343-9. PubMed ID: 3405342
    [Abstract] [Full Text] [Related]

  • 2. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. III. Human serum albumin-methotrexate derivative, its preparation and basic testing.
    Bures L, Bostík J, Motycka K, Spundová M, Rehák L.
    Neoplasma; 1988; 35(3):329-42. PubMed ID: 3405341
    [Abstract] [Full Text] [Related]

  • 3. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.
    Wosikowski K, Biedermann E, Rattel B, Breiter N, Jank P, Löser R, Jansen G, Peters GJ.
    Clin Cancer Res; 2003 May; 9(5):1917-26. PubMed ID: 12738750
    [Abstract] [Full Text] [Related]

  • 4. Control of solid tumor metastases with a high-molecular-weight derivative of methotrexate.
    Chu BC, Whiteley JM.
    J Natl Cancer Inst; 1979 Jan; 62(1):79-82. PubMed ID: 281578
    [Abstract] [Full Text] [Related]

  • 5. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. II. Chemotherapy of Gardner lymphosarcoma with pea seed lectin-methotrexate derivative.
    Bures L, Motycka K, Bostík J, Slavík K, Jirásek A.
    Neoplasma; 1986 Jan; 33(4):409-16. PubMed ID: 3762803
    [Abstract] [Full Text] [Related]

  • 6. Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.
    Hartung G, Stehle G, Sinn H, Wunder A, Schrenk HH, Heeger S, Kränzle M, Edler L, Frei E, Fiebig HH, Heene DL, Maier-Borst W, Queisser W.
    Clin Cancer Res; 1999 Apr; 5(4):753-9. PubMed ID: 10213209
    [Abstract] [Full Text] [Related]

  • 7. Markedly improved efficacy of edatrexate compared to methotrexate in a high-dose regimen with leucovorin rescue against metastatic murine solid tumors.
    Sirotnak FM, Otter GM, Schmid FA.
    Cancer Res; 1993 Feb 01; 53(3):587-91. PubMed ID: 8425192
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The in vivo antitumor activity of LHRH targeted methotrexate-human serum albumin nanoparticles in 4T1 tumor-bearing Balb/c mice.
    Taheri A, Dinarvand R, Ahadi F, Khorramizadeh MR, Atyabi F.
    Int J Pharm; 2012 Jul 15; 431(1-2):183-9. PubMed ID: 22531853
    [Abstract] [Full Text] [Related]

  • 12. Methotrexate-albumin and aminopterin-albumin effectively prevent experimental acute graft-versus-host disease.
    Wolff D, Frei E, Hofmeister N, Steiner B, Kleine HD, Junghanss C, Sievert K, Terpe H, Schrenk HH, Freund M, Hartung G.
    Transplantation; 2006 Aug 27; 82(4):527-33. PubMed ID: 16926597
    [Abstract] [Full Text] [Related]

  • 13. A phase II trial of methotrexate-human serum albumin (MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy.
    Vis AN, van der Gaast A, van Rhijn BW, Catsburg TK, Schmidt C, Mickisch GH.
    Cancer Chemother Pharmacol; 2002 Apr 27; 49(4):342-5. PubMed ID: 11914915
    [Abstract] [Full Text] [Related]

  • 14. Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone.
    Weigand M, Hartung G, Roboz J, Sieger S, Wolf M, Sinn H, Schrenk HH, Wiessler M, Frei E.
    Anticancer Drug Des; 2001 Apr 27; 16(4-5):227-37. PubMed ID: 12049481
    [Abstract] [Full Text] [Related]

  • 15. Prolonged survival of renal allograft in rats by methotrexate-albumin conjugates as immunosuppressive therapy.
    Hickstein H, Wolff D, Stange J, Frei E, Hartung G.
    Transplant Proc; 2008 Dec 27; 40(10):3725-7. PubMed ID: 19100475
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Targeted drug delivery by in vivo coupling to endogenous albumin: an albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis.
    Fiehn C, Kratz F, Sass G, Müller-Ladner U, Neumann E.
    Ann Rheum Dis; 2008 Aug 27; 67(8):1188-91. PubMed ID: 18408252
    [Abstract] [Full Text] [Related]

  • 19. Slower B16 melanoma growth but greater pulmonary colonization in calorie-restricted mice.
    Ershler WB, Berman E, Moore AL.
    J Natl Cancer Inst; 1986 Jan 27; 76(1):81-5. PubMed ID: 3455745
    [Abstract] [Full Text] [Related]

  • 20. Localization and distribution of magnetic chemotherapeutic drugs with magnetic targeting in rat brain.
    Li AM, Zhang CX, Fu XP, Zhang ZW, Xue QH, Yan RM, Yi LH.
    Chin Med J (Engl); 2005 May 20; 118(10):824-7. PubMed ID: 15989762
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 316.